Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
IGC Pharma ( (IGC) ) just unveiled an update.
On March 5, 2026, IGC Pharma, Inc. entered into a Securities Purchase Agreement with Vanquish Funding Group Inc., issuing a $353,050 promissory note, including a $46,050 original issue discount, for a purchase price of $307,000 maturing on February 28, 2027, with proceeds earmarked for general working capital. The note may be converted into common stock only upon an event of default at a 25% discount to the lowest trading price over the prior 10 trading days, subject to a 4.99% ownership cap for the holder and a 19.99% overall issuance cap absent shareholder approval, while the company also secured an additional approximately $219,000 loan from One Deck Capital, Inc. for working capital and general corporate purposes, collectively reinforcing its near-term liquidity through non-public, exempt financing structures.
The most recent analyst rating on (IGC) stock is a Hold with a $0.26 price target. To see the full list of analyst forecasts on IGC Pharma stock, see the IGC Stock Forecast page.
Spark’s Take on IGC Stock
According to Spark, TipRanks’ AI Analyst, IGC is a Neutral.
IGC Pharma’s overall stock score reflects significant financial challenges, particularly in profitability and valuation. Technical analysis shows a bearish trend, while the recent asset sale is a positive strategic move. The company needs to address revenue growth and profitability to improve its financial position.
To see Spark’s full report on IGC stock, click here.
More about IGC Pharma
IGC Pharma, Inc. is a biopharmaceutical company focused on developing therapies, with its operations funded in part through structured financing arrangements in the capital markets. The company utilizes debt instruments and equity-linked securities to secure working capital for general corporate purposes and ongoing development activities.
Average Trading Volume: 541,746
Technical Sentiment Signal: Strong Sell
Current Market Cap: $27.84M
For detailed information about IGC stock, go to TipRanks’ Stock Analysis page.